, Tracking Stock Market Picks
Enter Symbol:
Cardiovascular Systems Inc. (CSII) [hlAlert]

up 54.87 %

Cardiovascular Systems Inc. (CSII) downgraded to Hold with price target $35 by The Benchmark Company

Posted on: Tuesday,  Nov 26, 2013  8:25 AM ET by The Benchmark Company

The Benchmark Company rated Hold Cardiovascular Systems Inc. (NASDAQ: CSII) on 11/26/2013. Previously The Benchmark Company rated Speculative Buy Cardiovascular Systems Inc. (NASDAQ:
CSII) on 09/10/2013., when the stock price was $21.65. Since then, Cardiovascular Systems Inc. has gained 54.87% as of 11/26/2013's recent price of $33.53.
If you would have followed the previous The Benchmark Company's recommendation on CSII, you would have gained 54.87% of your investment in 77 days.

Cardiovascular Systems, Inc.(CSI) is a medical device company focused on developing and commercializing minimally invasive treatment solutions for vascular disease. The Company?s primary product, the Diamondback 360 PAD System, is a catheter-based platform capable of treating a range of plaque types in leg arteries both above and below the knee. In August 2007, the United States Food and Drug Administration (FDA) granted the Company 510(k) clearance for use of the Diamondback 360 as a therapy for treatment of patients with peripheral artery disease (PAD). As of June 30, 2009, it was selling the Diamondback 360 in 556 accounts that had completed an estimated 15,000 procedures. On February 25, 2009, Replidyne, Inc. completed its merger with Cardiovascular Systems, Inc. Pursuant to the merger, Replidyne merged with and into Cardiovascular Systems, Inc., with Cardiovascular Systems, Inc. continuing after the merger as the surviving company and a wholly owned subsidiary of Replidyne.

The Benchmark Company 's Equity Research team is one of the most experienced on the Street. Our analysts average almost two decades of sell-side research experience and many have substantial experience in the industries they cover as well. Our people give us the ability to deliver insightful and unique research seasoned by the experience of having lived through multiple bull and bear markets, and having covered their companies longer than most of their peers.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/26/2013 8:25 AM Hold
33.53 35.00
as of 12/13/2013
1 Week   
1 Month up  11.76 %
3 Months up  59.66 %
1 YTD up  167.17 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/10/2013 8:25 AM Buy
21.65 26.00
3/15/2013 8:25 AM Buy
20.20 24.00
12/18/2012 8:25 AM Buy
12.48 18.00
3/27/2012 10:25 AM Buy
9.51 15.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy